We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+36.08%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+531.4%
AUM
$4.08B
AUM Growth
+$236M
Cap. Flow
-$708M
Cap. Flow %
-17.33%
Top 10 Hldgs %
19.32%
Holding
5,845
New
764
Increased
1,966
Reduced
2,392
Closed
665

Sector Composition

Rank Sector Weight
1 Miscellaneous 34.65%
2 Technology 23.8%
3 Financials 7.62%
4 Industrials 7.22%
5 Healthcare 6.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VANI icon
4476
Vivani Medical
VANI
$112M
$3.75K ﹤0.01%
3,024
+427
+16% +$516
GRCE
4477
Grace Therapeutics
GRCE
$44.6M
$3.75K ﹤0.01%
1,652
+1,237
+298% +$3.42K
KG
4478
Kestrel Group
KG
$39.4M
$3.74K ﹤0.01%
416
-994
-70% -$11K
LPSN
4479
DELISTED
LivePerson
LPSN
$3.74K ﹤0.01%
+1,970
New +$4.74K
PRPL icon
4480
Purple Innovation
PRPL
$10.8M
$3.74K ﹤0.01%
+419
New +$5.14K
GNS icon
4481
Genius Group
GNS
$30.2M
$3.74K ﹤0.01%
+20,000
New +$5.51K
SWAG icon
4482
Stran & Co
SWAG
$29.1M
$3.73K ﹤0.01%
1,675
-425
-20% -$799
BLNE
4483
Beeline Holdings
BLNE
$29.3M
$3.73K ﹤0.01%
+3,060
New +$5.03K
SOMN
4484
The Southern Company 2025 Series A Corp Units
SOMN
$3.73K ﹤0.01%
+75
New +$3.8K
HHS icon
4485
Harte-Hanks
HHS
$34.3M
$3.73K ﹤0.01%
1,725
-270
-14% -$706
NCDL icon
4486
Nuveen Churchill Direct Lending
NCDL
$578M
$3.73K ﹤0.01%
+300
New +$4K
TIGO icon
4487
Millicom
TIGO
$15.5B
$3.72K ﹤0.01%
41
-9,521
-100% -$802K
FLYE
4488
Fly-E Group
FLYE
$2.3M
$3.72K ﹤0.01%
1,763
-1,147
-39% -$2.33K
JZ
4489
Jianzhi Education Technology Group
JZ
$1.09M
$3.72K ﹤0.01%
833
+700
+526% +$14.4K
BTBD icon
4490
BT Brands
BTBD
$12M
$3.71K ﹤0.01%
3,471
+1,563
+82% +$2.26K
WYY icon
4491
WidePoint Corp
WYY
$54.7M
$3.71K ﹤0.01%
212
+111
+110% +$1.04K
TNXP icon
4492
Tonix Pharmaceuticals
TNXP
$169M
$3.69K ﹤0.01%
289
-889
-75% -$11.5K
PBT
4493
Permian Basin Royalty Trust
PBT
$1.56B
$3.68K ﹤0.01%
147
-1,093
-88% -$27.7K
SCHX icon
4494
Schwab US Large- Cap ETF
SCHX
$74.6B
$3.68K ﹤0.01%
125
-99,332
-100% -$2.84M
SUNE
4495
SUNation Energy
SUNE
$15.6M
$3.67K ﹤0.01%
1,553
-863
-36% -$1.55K
TCRT icon
4496
Alaunos Therapeutics
TCRT
$2.77M
$3.66K ﹤0.01%
1,621
+38
+2% +$97
GTIM icon
4497
Good Times Restaurants
GTIM
$15.9M
$3.65K ﹤0.01%
2,592
-3,040
-54% -$3.9K
GXAI
4498
Gaxos.ai
GXAI
$7.83M
$3.64K ﹤0.01%
3,108
+1,385
+80% +$1.71K
ADIL
4499
Adial Pharmaceuticals
ADIL
$12.4M
$3.63K ﹤0.01%
1,419
+63
+5% +$125
BGDE
4500
Big Digital Energy Inc
BGDE
$32.6M
$3.62K ﹤0.01%
406
-2,041
-83% -$13.2K

Similar funds

Tower Research Capital (TRC)'s Q2 2026 Portfolio in Review

As of Q2 2026, Tower Research Capital (TRC) held 5,845 positions worth $4.08B, up 6.1% from $3.85B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Tower Research Capital (TRC) withdrew a net $708M in Q2 2026, closing 665 positions and reducing 2,392 holdings. Its most notable exit was iShares MSCI USA Min Vol Factor ETF, an estimated $13M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 29% a quarter earlier, followed by Technology and Financials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Core S&P 500 ETF worth $84M.

  • Tower Research Capital (TRC)'s largest Q2 2026 buy was iShares Core S&P 500 ETF: 112,156 shares worth $84M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $130M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2026 reduction was Direxion Daily Semiconductor Bull 3X ETF, cutting an estimated $361M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Min Vol Factor ETF in Q2 2026, selling an estimated $13M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 19% of its $4.08B portfolio in Q2 2026.
  • Tower Research Capital (TRC) opened 764 new positions and closed 665 in Q2 2026.
  • Tower Research Capital (TRC)'s portfolio value rose 6.1% quarter-over-quarter to $4.08B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.